<bill session="108" type="h" number="2491" updated="2013-07-14T19:01:31-04:00">
  <state datetime="2003-06-17">REFERRED</state>
  <status>
    <introduced datetime="2003-06-17"/>
  </status>
  <introduced datetime="2003-06-17"/>
  <titles>
    <title as="introduced" type="short">Greater Access to Affordable Pharmaceuticals Act</title>
    <title as="introduced" type="official">Entitled the "Greater Access to Affordable Pharmaceuticals Act".</title>
  </titles>
  <sponsor id="400121"/>
  <cosponsors>
    <cosponsor id="400007" joined="2003-06-17"/>
    <cosponsor id="400023" joined="2003-06-17"/>
    <cosponsor id="400039" joined="2003-06-17"/>
    <cosponsor id="400045" joined="2003-06-17"/>
    <cosponsor id="400050" joined="2003-06-17"/>
    <cosponsor id="400055" joined="2003-06-17"/>
    <cosponsor id="400057" joined="2003-06-17"/>
    <cosponsor id="400081" joined="2003-06-17"/>
    <cosponsor id="400103" joined="2003-06-19"/>
    <cosponsor id="400118" joined="2003-06-17"/>
    <cosponsor id="400120" joined="2003-06-17"/>
    <cosponsor id="400164" joined="2003-06-17"/>
    <cosponsor id="400200" joined="2003-06-17"/>
    <cosponsor id="400216" joined="2003-10-16"/>
    <cosponsor id="400221" joined="2003-06-17"/>
    <cosponsor id="400230" joined="2003-06-17"/>
    <cosponsor id="400246" joined="2003-06-17"/>
    <cosponsor id="400253" joined="2003-06-17"/>
    <cosponsor id="400281" joined="2003-06-19"/>
    <cosponsor id="400289" joined="2003-06-19"/>
    <cosponsor id="400294" joined="2003-06-17"/>
    <cosponsor id="400303" joined="2003-06-17"/>
    <cosponsor id="400306" joined="2003-07-08"/>
    <cosponsor id="400308" joined="2003-06-17"/>
    <cosponsor id="400347" joined="2003-06-17"/>
    <cosponsor id="400357" joined="2003-06-19"/>
    <cosponsor id="400360" joined="2003-10-30"/>
    <cosponsor id="400366" joined="2003-06-17"/>
    <cosponsor id="400382" joined="2003-11-05"/>
    <cosponsor id="400390" joined="2004-06-17"/>
    <cosponsor id="400421" joined="2003-06-17"/>
    <cosponsor id="400425" joined="2003-06-17"/>
    <cosponsor id="400430" joined="2003-06-17"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-06-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-17">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-06-17">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2003-06-24">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2003-06-25">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
      <committee name="House Judiciary"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSJU03" subcommittee="Courts, the Internet, and Intellectual Property" name="House Judiciary"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="108" type="s" number="1225"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Actions and defenses"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Antitrust law"/>
    <term name="Commerce"/>
    <term name="Consent decrees"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Generic drugs"/>
    <term name="Government operations and politics"/>
    <term name="Intellectual property"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Punitive damages"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>6/17/2003--Introduced.
Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream.</summary>
</bill>
